Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: Comparison between mono- and bisquaternary ammonium salts

Journal of Medicinal Chemistry

Volumn 43, Issue 3, 2000, Pages 505-516

  Calas, Michèle ^a   Ancelin, Marie L ^a   Cordina, Gérard ^a   Portefaix, Philippe ^a   Piquet, Gilles ^a   Vidal Sailhan, Valérie ^a   Vial, Henri ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE DERIVATIVE; PHOSPHOLIPID; QUATERNARY AMMONIUM DERIVATIVE;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIPOPHILICITY; MOLECULAR SIZE; PHOSPHOLIPID METABOLISM; PLASMODIUM FALCIPARUM; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIMALARIALS; ERYTHROCYTES; HUMANS; LIGANDS; PHOSPHOLIPIDS; PLASMODIUM FALCIPARUM; QUATERNARY AMMONIUM COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034628578     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9911027     Document Type: Article

References (24)

1. Wernsdorfer, W. H.; Payne, D. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol. Ther. 1991, 50, 95-121.
2. White, N. J.; Olliaro, P. L. Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol. Today 1996, 12, 399-401.
3. Butler, D.; Maurice, J.; O'Brien, C. Briefing malaria. Nature 1997, 386, 535-541.
4. Vial, H. J.; Ancelin, M. L. Malarial lipids. In Subcellular Biochemistry; Avila, J. L., Harris, J. R., Eds.; Plenum Press: New York, 1992; pp 259-306.
5. Vial, H. J.; Ancelin, M. L. Malarial lipids. In Malaria: Parasite Biology, Pathogenesis, Protection; Sherman, I. W., Ed.; ASM Press: Washington, D. C., 1998; Chapter 11, pp 159-175.
6. Ancelin, M. L.; Calas, M.; Bompart, J.; Cordina, G.; Martin, D.; Ben Bari, M.; Jei, T.; Druilhe, P.; Vial, H. Antimalarial activity of 77 phospholipid polar head analogues: close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth. Blood 1998, 91, 1426-1437.
7. Ancelin, M. L.; Parant, M.; Thuet, M. J.; Philippot, J. R.; Vial H. J. Increased permeability to choline in simian erythrocytes after Plasmodium knowlesi infection. Biochem. J. 1991, 273, 701-709.
8. Calas, M.; Cordina, G.; Bompart, J.; Ben Bari, M.; Jei, T.; Ancelin, M. L.; Vial, H. Antimalarial activity of molecules interfering with Plasmodium falciparum phospholipid metabolism. Structure-activity relationship analysis. J. Med. Chem. 1997, 40, 3557-3566.
9. Antimalarial drugs I. Biological background, experimental methods and drug resistance; Peters, W., Richards, W. H. G., Eds.; Springer-Verlag: Berlin, 1984; Vol. 68/I, p 484.
10. De Vries, P. J.; Dien, T. K. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 1996, 52, 818-836.
11. Changeux, J. P.; Galzi, J. L.; Devillers-Thiéry, A.; Bertrand, D. The functional architecture of the acetylcholine nicotinic receptor explored by affinity labeling and site-directed mutagenesis. Quart. Rev. Biophys. 1992, 25, 395-432.
12. Melchiorre, C.; Minarini, A.; Angeli, P.; Giardina, D.; Gulini, U.; Quaglia, W. Polymethylene tetramines as muscarinic receptor probes. TIPS 1989, December, 55-59.
13. Kosower, E. M. A structural and dynamic model for the nicotinic acetylcholine receptor. Eur. J. Biochem. 1987, 168, 431-449.
14. Costa, T.; Wüster, M.; Herz, A.; Shimohigashi, Y.; Chen, H. C.; Rodbard, D. Receptor binding and biological activity of bivalent enkephalins. Biochem. Pharmacol. 1985, 34, 25-30.
15. Portoghese, P. S.; Ronsisvalle, G.; Larson, DL.; Yim, C. B.; Sayre, L. M.; Takemori, A. E. Opioid agonist and antagonist bivalent ligands as receptor probes. Life Sci. 1982, 31, 1283-1286.
16. Portoghese, P. S. Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists. Trends Pharmacol. Sci. 1989, 10, 230-235.
17. Portoghese, P. S. Bivalent ligands in the development of selective opioid receptor antagonists. In Trends in medicinal Chemistry; Mutschler, E., Winterfeldt, E., Eds.; 1987, pp 327-336.
18. Barrow, R. B.; Ing, H. R. Curare-like action of polymethylene Bis-quaternary ammonium salts. Br. J. Pharmacol. 1948, 3, 298-304.
19. Roberts, E.; Tamaru, M. The ligand binding site of the synaptosomal choline transporter: a provisional model based on inhibition studies. Neurochem. Res. 1992, 17, 509-528.
20. Bergmann, F.; Segal, R. The relationship of quaternary ammonium salts to the anionic sites of true and pseudo cholinesterase. Biochem. J. 1954, 58, 692-698.
21. Friedman, L.; Arnon, S. Halopolycarbon homologation. J. Am. Chem. Soc. 1974, 96, 7101.
22. Richards, W. H.; Maples, B. K. Studies on Plasmodium falciparum in continuous culture. 1. The effects of chloroquine and pyrimethamine on parasite growth. Ann. Trop. Med. Parasitol. 1977, 73, 99-108.
23. Jensen, J. B.; Trager, W. Plasmodium falciparum in culture: use of outdated erythrocytes and description of the candle-jar method. J. Parasitol. 1977, 63, 883-886.
24. Desjardins, R. E.; Canfield, C. J.; Haynes, J. D.; Chulay, J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 1979, 16, 710-718.